Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
IBX Imagion Biosystems Ltd
0.0250.0000.00%
YOY
Do not show
Hide blank lines
(FY)2021/12/30(Q4)2021/12/30(FY)2020/12/30(Q4)2020/12/30
Financial Ratios
Efficiency Ratios
Receivable Turnover
-- 7.4291 -- -- -- -- -- --
Fixed Assets Turnover
117.83% 0.4517 -- -- -60.36% 0.2074 -- --
Total Asset Rate
-23.86% 0.0165 -- -- -73.48% 0.0217 -- --
ROE
31.94% -45.956% -- -- 32.69% -67.525% -- --
ROA
24.45% -42.677% -- -- 17.22% -56.490% -- --
ROIC
27.22% -44.796% -- -- 30.55% -61.553% -- --
Profitability Ratios
Gross Margin
0.00% 100.000% -- -- 0.00% 100.000% -- --
EBIT Margin
0.73% -2585.362% -- -- -212.56% -2604.326% -- --
Net Margin
0.78% -2587.210% -- -- -212.10% -2607.469% -- --
EBITDA Margin
0.71% -2411.684% -- -- -204.14% -2429.050% -- --
Interest Coverage (T)
-68.87% -1.4K -- -- -121.69% -828.6995 -- --
R & D Expense Ratio
-16.50% 1161.200% -- -- 151.80% 1390.630% -- --
Sales Expense Ratio
-- 0.000% -- -- -- 0.000% -- --
Administration Expense Rate
17.63% 1614.360% -- -- 210.36% 1372.430% -- --
Financial Health Ratios
Long-Term Debt to Equity Ratio
-90.10% 0.232% -90.10% 0.232% -88.67% 2.344% -88.67% 2.344%
Total Assets to Common Equity Ratio
-2.97% 106.087% -2.97% 106.087% -33.27% 109.332% -33.27% 109.332%
Interest-Bearing Liabilities To Asset Ratio
-93.04% 0.326% -93.04% 0.326% -73.99% 4.682% -73.99% 4.682%
Current Ratio
18.99% 17.7444 18.99% 17.7444 435.73% 14.9125 435.73% 14.9125
Quick Ratio
18.07% 17.3012 18.07% 17.3012 452.90% 14.6534 452.90% 14.6534
Growth Ratios
Growth Ratios
Revenue CAGR (3Y)
-94.24% 6.741% -- -- -- 117.109% -- --

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
CEO: --
Market: ASX
Watchlist